Abstract:The optimal structure design of nanocarriers to inhibit premature release of anticancer drugs from nanocarriers during blood circulation and improve drug release inside tumor cells is still a significant issue for polymer micelles applied to antitumor drug delivery. Herein, in order to balance the contradiction between polymer micellar stability and drug release, dual-sensitive cleavable cross-linkages of benzoic imine conjugated disulfide bonds were introduced into the core of the amphiphilic copolymer micelles to form core-cross-linked micelles. First, biodegradable poly(ethylene glycol)-b-(polycaprolactone-g-poly(methacrylic acid-p-hydroxy benzaldehyde-cystamine)), i.e. mPEG-b-(PCL-g-P(MAA-Hy-Cys)) (PECMHC) copolymers were synthesized and assembled into PECMHC micelles (PECMHC Ms). Then, simply by introducing H2O2 to the PECMHC Ms dispersions to oxidate the thiol groups of cystamine moieties in the core, core-cross-linked PECMHC micelles (cc-PECMHC Ms) ∼100 nm in size were readily obtained in water. In vitro studies of doxorubicin (DOX)-loaded cc-PECMHC Ms show that the cross-linked core impeded the drug release in the physical conditions, owing to the high stability of the micelles against both extensive dilution and salt concentration, while it greatly accelerated DOX release in mildly acidic (pH ∼5.0-6.0) medium with glutathione, owing to the coordination of the pH-sensitive cleaving of benzoic imine bonds and the reduction-sensitive cleaving of disulfide bonds. The in vivo tissue distribution and tumor accumulation of the DOX-loaded cc-PECMHC Ms were monitored via fluorescence images of DOX. DOX-loaded cc-PECMHC Ms exhibited enhanced tumor accumulation because of their high stability in blood circulation and less DOX premature release. Therefore, the cc-PECMHC Ms with dual-sensitive cleavable bonds in the cross-linked core were of excellent biocompatibility, high extracellular stability and had intelligent intracellular drug release properties, indicating promise as candidates for anticancer drug delivery.

Biodegradable Core-Shell Copolymer-Phospholipid Nanoparticles for Combination Chemotherapy: an in Vitro Study.

Polymer-lipid Hybrid Nanoparticles Synchronize Pharmacokinetics of Co-Encapsulated Doxorubicin-Mitomycin C and Enable Their Spatiotemporal Co-Delivery and Local Bioavailability in Breast Tumor.

"Shell-Core" Bilayer Nanoparticle as Chemotherapeutic Drug Co-Delivery Platforms Render Synchronized Microenvironment Respond and Enhanced Antitumor Effects

Complex Polymeric Nanomicelles Co-Delivering Doxorubicin and Dimethoxycurcumin for Cancer Chemotherapy

Synergistic Breast Tumor Cell Killing Achieved by Intracellular Co-Delivery of Doxorubicin and Disulfiram Via Core-Shell-corona Nanoparticles

Amphiphilic star copolymers-mediated co-delivery of doxorubicin and avasimibe for effective combination chemotherapy

Dendritic polymer prodrug-based unimolecular micelles for pH-responsive co-delivery of doxorubicin and camptothecin with synergistic controlled drug release effect

Polymer–Drug Nanoparticles Combine Doxorubicin Carrier and Heparin Bioactivity Functionalities for Primary and Metastatic Cancer Treatment

Doxorubicin/cisplatin Co-Loaded Hyaluronic Acid/chitosan-Based Nanoparticles for in Vitro Synergistic Combination Chemotherapy of Breast Cancer

Interface Cisplatin-Crosslinked Doxorubicin-Loaded Triblock Copolymer Micelles for Synergistic Cancer Therapy.

Doxorubicin- and cisplatin-loaded nanostructured lipid carriers for breast cancer combination chemotherapy

Synergistic Combination Therapy Using A Lipid Shell-Droplet Core Nanosphere with Tunable Thickness

Fabrication of Core/shell/shell Structure Nanoparticle with Anticancer Drug and Dual-Photosensitizer Co-Loading for Synergistic Chemotherapy and Photodynamic Therapy

Targeted Biomimetic Nanoparticles for Synergistic Combination Chemotherapy of Paclitaxel and Doxorubicin

Combination Chemotherapy Of Doxorubicin, All-Trans Retinoic Acid And Low Molecular Weight Heparin Based On Self-Assembled Multi-Functional Polymeric Nanoparticles

Balancing the Stability and Drug Release of Polymer Micelles by the Coordination of Dual-Sensitive Cleavable Bonds in Cross-Linked Core.

Efficient Co-delivery of Doxorubicin and Methotrexate by Ph-Sensitive Dual-Functional Nanomicelles for Enhanced Synergistic Antitumor Efficacy

Palmitoyl Ascorbate and Doxorubicin Co-Encapsulated Liposome for Synergistic Anticancer Therapy.

Dual Redox/ph-Responsive Hybrid Polymer-Lipid Composites: Synthesis, Preparation, Characterization and Application in Drug Delivery with Enhanced Therapeutic Efficacy

Biodegradable Core-Shell Carriers for Simultaneous Encapsulation of Synergistic Actives.

Core/Shell PEGS/HA Hybrid Nanoparticle Via Micelle-Coordinated Mineralization for Tumor-Specific Therapy.